Keita Tamura

KEYNOTE-119: Phase III study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple negative breast cancer (mTNBC)

Javier Cortés, Oleg Lipatov, S. Im et al. · Annals of Oncology · 2019 · 129 citations

Breast Oncology, Oncology, Medicine +7

Prognostic Significance of Time to Castration Resistance in Patients With Metastatic Castration-sensitive Prostate Cancer

Hideaki Miyake, Yuto Matsushita, Hiromitsu Watanabe et al. · Anticancer Research · 2019 · 64 citations · Full text

Discovery of lipid biomarkers correlated with disease progression in clear cell renal cell carcinoma using desorption electrospray ionization imaging mass spectrometry

Keita Tamura, Makoto Horikawa, Shumpei Sato et al. · Oncotarget · 2019 · 46 citations · Full text

Initial Experience of Robot-Assisted Partial Nephrectomy Using Hinotori Surgical Robot System: Single Institutional Prospective Assessment of Perioperative Outcomes in 30 Cases

Hideaki Miyake, Daisuke Motoyama, Yuto Matsushita et al. · Journal of Endourology · 2023 · 45 citations

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer

Seock‐Ah Im, Alessandra Gennari, Y.H. Park et al. · ESMO Open · 2023 · 43 citations · Full text